Unaudited Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues
Patent licensing fees	$ 1,045,000	$ 202,500
Cost of revenue
Litigation and licensing expenses	561,552	187,973
Gross profit	483,448	14,527
Operating expenses
Selling, general and administrative expenses	577,279	777,857
Total operating expenses	577,279	777,857
Income (loss) from operations	(93,831)	(763,330)
Other expenses
Change in fair market value of warrant liability	(199,422)	(8,566)
Interest expense	(138,189)	(137,469)
Total other expenses	(337,611)	(146,035)
Loss before income tax	(431,442)	(909,365)
Income tax expense		(30,000)
Net loss	$ (431,442)	$ (939,365)
Loss per share - basic (in Dollars per share)	$ (0.08)	$ (0.17)
Weighted average shares outstanding - basic (in Shares)	5,331,973	5,331,973